The European Medicines Agency (EMA) has approved the expansion of Greenwich LifeSciences’ Phase III FLAMINGO-01 breast cancer ...
Bonus Apr 05, 2010 Apr 06, 2010 Feb 25, 2010 Bonus Ratio: 1 share(s) for every 2 shares held Bonus Aug 30, 2006 Aug 31, 2006 Apr 28, 2006 Bonus Ratio: 1 share(s) for every 1 shares held Zydus ...
The Quarterly Results page of Zydus Lifesciences Ltd. presents the key result items, its comparison with the sector peers and its previous 5 Quarterly Results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback